235 related articles for article (PubMed ID: 28545044)
1. Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
Velasquez-Mao AJ; Tsao CJM; Monroe MN; Legras X; Bissig-Choisat B; Bissig KD; Ruano R; Jacot JG
PLoS One; 2017; 12(5):e0177824. PubMed ID: 28545044
[TBL] [Abstract][Full Text] [Related]
2. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
3. Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.
Jiang G; Herron TJ; Di Bernardo J; Walker KA; O'Shea KS; Kunisaki SM
Stem Cells Transl Med; 2016 Dec; 5(12):1595-1606. PubMed ID: 27465073
[TBL] [Abstract][Full Text] [Related]
4. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.
Moschidou D; Mukherjee S; Blundell MP; Jones GN; Atala AJ; Thrasher AJ; Fisk NM; De Coppi P; Guillot PV
Stem Cells Dev; 2013 Feb; 22(3):444-58. PubMed ID: 23050522
[TBL] [Abstract][Full Text] [Related]
5. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
6. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
[TBL] [Abstract][Full Text] [Related]
7. Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.
Wang H; Xi Y; Zheng Y; Wang X; Cooney AJ
Stem Cell Res; 2016 Mar; 16(2):522-30. PubMed ID: 26972055
[TBL] [Abstract][Full Text] [Related]
8. Amniotic fluid-derived stem cells demonstrate limited cardiac differentiation following small molecule-based modulation of Wnt signaling pathway.
Connell JP; Ruano R; Jacot JG
Biomed Mater; 2015 Mar; 10(3):034103. PubMed ID: 25784677
[TBL] [Abstract][Full Text] [Related]
9. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
[TBL] [Abstract][Full Text] [Related]
10. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
[TBL] [Abstract][Full Text] [Related]
11. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
12. Selective isolation of nanog-positive human amniotic mesenchymal cells and differentiation into cardiomyocytes.
Otaka S; Nagura S; Koike C; Okabe M; Yoshida T; Fathy M; Yanagi K; Misaki T; Nikaido T
Cell Reprogram; 2013 Feb; 15(1):80-91. PubMed ID: 23298400
[TBL] [Abstract][Full Text] [Related]
13. High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
Liu T; Zou G; Gao Y; Zhao X; Wang H; Huang Q; Jiang L; Guo L; Cheng W
Stem Cells Dev; 2012 Aug; 21(12):2322-32. PubMed ID: 22264161
[TBL] [Abstract][Full Text] [Related]
14. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells.
Tsai MS; Hwang SM; Tsai YL; Cheng FC; Lee JL; Chang YJ
Biol Reprod; 2006 Mar; 74(3):545-51. PubMed ID: 16306422
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
16. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
[TBL] [Abstract][Full Text] [Related]
17. Controlled Release of Small Molecules for Cardiac Differentiation of Pluripotent Stem Cells.
Tsao CJ; Taraballi F; Pandolfi L; Velasquez-Mao AJ; Ruano R; Tasciotti E; Jacot JG
Tissue Eng Part A; 2018 Dec; 24(23-24):1798-1807. PubMed ID: 30129882
[TBL] [Abstract][Full Text] [Related]
18. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Nanog and Sox-2 genes following ectopic expression of Oct-4 in amniotic fluid mesenchymal stem cells.
Wang KH; Kao AP; Chang CC; Lin TC; Kuo TC
Biotechnol Appl Biochem; 2015; 62(5):591-7. PubMed ID: 25385323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
